Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from editorial

  • You have access
    Lifestyle drugs, mood, behaviour and cognition
    Simon N. Young
    J Psychiatry Neurosci March 01, 2003 28 (2) 87-89;
  • You have access
    Treating mood disorders
    Russell T. Joffe
    J Psychiatry Neurosci January 01, 2003 28 (1) 9-10;
  • You have access
    Chirality and drugs used to treat psychiatric disorders
    Glen B. Baker, Trevor I. Prior and Ronald T. Coutts
    J Psychiatry Neurosci November 01, 2002 27 (6) 401-403;
  • You have access
    The ethics of placebo in clinical psychopharmacology: the urgent need for consistent regulation
    Simon N. Young and Lawrence Annable
    J Psychiatry Neurosci September 01, 2002 27 (5) 319-321;
  • You have access
    Why treat depression differently from other medical problems?
    Pierre Blier
    J Psychiatry Neurosci July 01, 2002 27 (4) 231-232;
  • You have access
    JPN and the electronic revolution
    John Hoey and Anne Marie Todkill
    J Psychiatry Neurosci May 01, 2002 27 (3) 158-160;
  • You have access
    Increasing sophistication of the pharmacotherapy of mood disorders
    Russell T. Joffe
    J Psychiatry Neurosci March 01, 2002 27 (2) 89;
  • You have access
    Neuroprotective effects of antidepressant and mood stabilizing drugs
    L. Trevor Young
    J Psychiatry Neurosci January 01, 2002 27 (1) 8-9;

Pages

  • Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire